Dr Harry Fonseca Williams MSc PhD

Chairman & CSO

Harry has been studying the pathology of snakebite since the beginning of his PhD. He has diverse expertise in the field of venomology and immunology which are combined with a passion for venomous reptiles themselves.

Dr V Rajendran MSc PhD MRSC FHEA

Director & CEO

Raj has more than a decade of experience in drug development, manufacturing, compound synthesis, purification and characterisation. He is also experienced in project management and business development.

Steve Trim BSc CBiol MRSB

Venom & Drug Discovery Advisor

Steve is the Founder, Chief Scientific Officer and Managing Director of Venomtech. He has over 10 years of expertise in venoms and two decades of experience in drug discovery.

Dr C Soundara Raj MD (Gen.Med.)

Chief Medical Advisor

Soundara Raj is the founder of TCR Multispeciality Hospital. He has been delivering pioneering medical care to snakebite victims and saved many hundreds of lives in his career.

Dr Stephen Paul Samuel MBBS MSc PhD

Clinical Scientific Advisor

Stephen works as a Medical Registrar in Queen Elizabeth Hospital, UK. He has commendable experience in snakebite treatments and research. Further, actively involved in snakebite awareness programmes among students and vulnerable societies in India.

Prof Ketan Patel MSc PhD

Senior Scientific Advisor

Ketan is a Professor of Regenerative Medicine and Developmental Biology in the UK. He is currently developing novel treatments for snakebite induced tissue damage and muscle degeneration.

Kate Fonseca Williams MSc

Head of Culture

Kate has many years of experience implementing organisational change and transformation initiatives as well as designing and delivering learning and development programmes in global and medium sized organisations.

Padmini Ramachandran

Genomics Advisor

Padmini is a public health official at Office of Regulatory Science, FDA, USA. She specializes in data visualization and data modelling of next gen sequencing data. Her research interests include using metagenomics to track pathogens.

Investors & partners